John Colwell to Diabetes Complications
This is a "connection" page, showing publications John Colwell has written about Diabetes Complications.
Connection Strength
0.904
-
Racial disparities in trends for cardiovascular disease and procedures among hospitalized diabetic patients. Ethn Dis. 2008; 18(2):131-5.
Score: 0.254
-
Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus. Am J Cardiovasc Drugs. 2004; 4(2):87-106.
Score: 0.192
-
Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus. Metabolism. 1992 May; 41(5 Suppl 1):7-10.
Score: 0.086
-
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care. 2010 Jun; 33(6):1395-402.
Score: 0.075
-
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation. 2010 Jun 22; 121(24):2694-701.
Score: 0.075
-
VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis. Haemostasis. 1986; 16(6):433-8.
Score: 0.055
-
Is aspirin effective in diabetic patients? Yes. J Thromb Haemost. 2005 Dec; 3(12):2612-4.
Score: 0.055
-
Atherosclerosis in diabetes mellitus. J Chronic Dis. 1981; 34(1):1-4.
Score: 0.039
-
Aspirin therapy in diabetes. Diabetes Care. 1997 Nov; 20(11):1767-71.
Score: 0.031
-
Effect of resection of adipose tissue on the diabetes and hyperinsulinism of benign symmetric lipomatosis. Diabetes. 1972 Jan; 21(1):13-5.
Score: 0.021
-
Diabetes research in South Carolina: past, present, and future. J S C Med Assoc. 1998 Nov; 94(11):502-8.
Score: 0.008
-
Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with an without vascular disease. Metabolism. 1977 Mar; 26(3):279-85.
Score: 0.007
-
Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation. Diabetes. 1972 Feb; 21(2):108-13.
Score: 0.005